SUHAX DWS Health and Wellness A Forecast, Technical & Fundamental Analysis

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), AstraZeneca PLC (NYSE:AZN), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD).

The investment seeks long-term growth of capital. Under normal circumstances, the fund will invest at least 80% of net assets, plus the amount of any borrowings for investment purposes, in equity securities of companies in the health care and wellness sectors. It invests primarily in securities of U.S. companies, but may invest in foreign companies as well. The fund may invest in companies of any size. While the fund invests mainly in common stocks, it may also invest up to 20% of total assets in U.S. Treasury and U.S. agency debt obligations.

The average market capitalization across the DWS Health and Wellness A MF is 343.92B. The market cap for tickers in the group ranges from 181.18B to 1.12T. LLY holds the highest valuation in this group at 1.12T. The lowest valued company is GILD at 181.18B.

The average weekly volume growth across all stocks in the DWS Health and Wellness A MF was 60%. For the same stocks of the MF, the average monthly volume growth was 38% and the average quarterly volume growth was 17%